[Abstract Only] Randomized Trial: Pembrolizumab for Early Triple-Negative Breast Cancer
8 Mar, 2020 | 20:17h | UTCPembrolizumab for Early Triple-Negative Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Neoadjuvant and Adjuvant Pembrolizumab in Early Triple-Negative Breast Cancer – ASCO Post (free)